VISION IN THE FUTURE

News

Re-Vana Therapeutics Raises $3.25 Million in Pre-Series A Financing

by | Jun 2, 2020 | News | 0 comments

Belfast, Northern Ireland – June 2, 2020 – Re-Vana Therapeutics Ltd, a privately-held specialty therapeutic and drug delivery company developing sustained-release therapeutics for significant sight-threatening ocular diseases, today announced that it has closed $3.25 million in pre-series A financing. The pre-series A round was oversubscribed by more than $1 million and closed in two tranches…

Read the full press release here >

Do NOT follow this link or you will be banned from the site!